2-79120891-G-C

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_002909.5(REG1A):​c.30G>C​(p.Leu10Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000534 in 1,613,152 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0029 ( 2 hom., cov: 31)
Exomes 𝑓: 0.00029 ( 0 hom. )

Consequence

REG1A
NM_002909.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.106

Publications

1 publications found
Variant links:
Genes affected
REG1A (HGNC:9951): (regenerating family member 1 alpha) This gene is a type I subclass member of the Reg gene family. The Reg gene family is a multigene family grouped into four subclasses, types I, II, III and IV, based on the primary structures of the encoded proteins. This gene encodes a protein that is secreted by the exocrine pancreas. It is associated with islet cell regeneration and diabetogenesis and may be involved in pancreatic lithogenesis. Reg family members REG1B, REGL, PAP and this gene are tandemly clustered on chromosome 2p12 and may have arisen from the same ancestral gene by gene duplication. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 2-79120891-G-C is Benign according to our data. Variant chr2-79120891-G-C is described in ClinVar as Benign. ClinVar VariationId is 737592.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.106 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002909.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
REG1A
NM_002909.5
MANE Select
c.30G>Cp.Leu10Leu
synonymous
Exon 2 of 6NP_002900.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
REG1A
ENST00000233735.2
TSL:1 MANE Select
c.30G>Cp.Leu10Leu
synonymous
Exon 2 of 6ENSP00000233735.1P05451
REG1A
ENST00000461579.1
TSL:1
n.402G>C
non_coding_transcript_exon
Exon 1 of 2
REG1A
ENST00000488524.1
TSL:1
n.229G>C
non_coding_transcript_exon
Exon 2 of 3

Frequencies

GnomAD3 genomes
AF:
0.00291
AC:
442
AN:
151748
Hom.:
2
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0103
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000723
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.000960
GnomAD2 exomes
AF:
0.000796
AC:
200
AN:
251144
AF XY:
0.000523
show subpopulations
Gnomad AFR exome
AF:
0.0116
Gnomad AMR exome
AF:
0.000232
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000264
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000287
AC:
419
AN:
1461288
Hom.:
0
Cov.:
30
AF XY:
0.000243
AC XY:
177
AN XY:
726956
show subpopulations
African (AFR)
AF:
0.0107
AC:
357
AN:
33450
American (AMR)
AF:
0.000380
AC:
17
AN:
44680
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26120
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39688
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86182
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53398
Middle Eastern (MID)
AF:
0.000694
AC:
4
AN:
5766
European-Non Finnish (NFE)
AF:
0.00000810
AC:
9
AN:
1111648
Other (OTH)
AF:
0.000480
AC:
29
AN:
60356
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
20
40
61
81
101
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00291
AC:
442
AN:
151864
Hom.:
2
Cov.:
31
AF XY:
0.00310
AC XY:
230
AN XY:
74240
show subpopulations
African (AFR)
AF:
0.0103
AC:
425
AN:
41388
American (AMR)
AF:
0.000722
AC:
11
AN:
15240
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5134
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4808
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10544
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
67974
Other (OTH)
AF:
0.000950
AC:
2
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
20
39
59
78
98
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000254
Hom.:
0
Bravo
AF:
0.00313
EpiCase
AF:
0.00
EpiControl
AF:
0.0000594

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
2.0
DANN
Benign
0.62
PhyloP100
-0.11
PromoterAI
-0.024
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113485193; hg19: chr2-79348017; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.